In this research project, the focus is on improving the effectiveness of cancer detection and treatment using hybrid molecule Nitrogen-Doped Graphene Quantum Dots (N-GQDs). Motivated by the pressing need to enhance current cancer diagnosis and treatment methods, given cancer's status as the second leading cause of global death, the study aims to address the limitations of existing diagnostic techniques, which often fail to detect early-stage cancers promptly. N-GQDs show promise as nanoscale molecules with unique quantum properties for cancer imaging and drug delivery. The objective is to refine the drug delivery aspect of N-GQDs to enable more efficient detection and destruction of early-stage, multidrug-resistant lung, breast, and ovarian cancers. The research seeks to create less demanding yet more effective treatment methods, exploring properties of N-GQDs and comparing anticancer drugs, such as pyrimethamine, methotrexate, and doxorubicin, bonded to N-GQDs. The methodology involves collecting experimental data from existing scholarly articles, analyzing quantitative and qualitative factors, and proposing an ideal anticancer drug for delivery via N-GQDs, contributing to the development of a safer, more efficient cancer treatment option.